Skip to main content
Home

Language & Country Selector for Desktop

language-selector-globe Philippines | en

Choose Location

  • International
  • Americas
  • Europe
  • Middle East & Africa
  • Asia Pacific
  • Global | en
  • Sandoz | en
  • Novartis Foundation | en
  • Argentina | es
  • Venezuela | es
  • Brazil | pt
  • Canada | en
  • Canada | fr
  • Central America | es
  • Colombia | es
  • Latin America | es
  • Mexico | es
  • United States | en
  • Austria | de
  • Belgium | fr
  • Bulgaria | bg
  • Czech Republic | cs
  • Czech Republic | cs
  • Czech Republic | en
  • Denmark | da
  • Estonia | et
  • Finland | fi
  • France | fr
  • Germany | de
  • Greece | el
  • Hungary | hu
  • Ireland | en
  • Italy | it
  • Latvia | lv
  • Lithuania | lt
  • Netherlands | nl
  • Norway | no
  • Poland | pl
  • Portugal | pt
  • Romania | ro
  • Russia | ru
  • Serbia | sr
  • Slovakia | sk
  • Spain | es
  • Sweden | sv
  • Switzerland | de
  • Switzerland | fr
  • United Kingdom | en
  • Egypt | en
  • South Africa | en
  • Turkey | tr
  • Australia | en
  • Bangladesh | en
  • Hong Kong S.A.R. | zh
  • India | en
  • Indonesia | en
  • Japan | ja
  • Korea | ko
  • Mainland China | zh
  • Malaysia | en
  • Pakistan | en
  • Philippines | en
  • Singapore | en
  • Taiwan | zh

Language & Country Selector for Mobile

language-selector-globe Philippines

Choose Location

International Americas Europe Middle East & Africa Asia Pacific
  • Argentina | es
  • Venezuela | es
  • Australia | en
  • Austria | de
  • Bangladesh | en
  • Belgium | fr
  • Brazil | pt
  • Bulgaria | bg
  • Canada | en
  • Canada | fr
  • Central America | es
  • Colombia | es
  • Czech Republic | cs
  • Czech Republic | cs
  • Czech Republic | en
  • Denmark | da
  • Egypt | en
  • Estonia | et
  • Finland | fi
  • France | fr
  • Germany | de
  • Global | en
  • Greece | el
  • Hong Kong S.A.R. | zh
  • Hungary | hu
  • India | en
  • Indonesia | en
  • Ireland | en
  • Italy | it
  • Japan | ja
  • Korea | ko
  • Latin America | es
  • Latvia | lv
  • Lithuania | lt
  • Mainland China | zh
  • Malaysia | en
  • Mexico | es
  • Netherlands | nl
  • Norway | no
  • Pakistan | en
  • Philippines | en
  • Poland | pl
  • Portugal | pt
  • Romania | ro
  • Russia | ru
  • Sandoz | en
  • Novartis Foundation | en
  • Serbia | sr
  • Singapore | en
  • Slovakia | sk
  • South Africa | en
  • Spain | es
  • Sweden | sv
  • Switzerland | de
  • Switzerland | fr
  • Taiwan | zh
  • Turkey | tr
  • United Kingdom | en
  • United States | en
    • About
      • Novartis in Philippines
      • Strategy
      • Diversity and Inclusion
      • People and Culture
      • Products
      • Country Leadership Team
      • Contact
      About
    • Patients and Caregivers
      • Novartis Commitment to Patients and Caregivers
      • Diseases
      • Patient resources
      • Products
      • Adverse Event Reporting
      Patients and Caregivers
    • Healthcare Professionals
      • Healthcare professional country resource
      • Products
      • Novartis Pipeline
      • Adverse Event Reporting
      • Novartis Clinical Trials
      Healthcare Professionals
    • ESG
      • Ethical Behavior
        • Code of Ethics
        • SpeakUp
      • Ethics, Risk and Compliance
      • Access
      • Environmental Sustainability
      • Global Health
      ESG
    • News
      • News Archive
      • Stories
      • Contacts
      News
    • Careers
      • Career Search
      • Meet the teams
      • Personal Growth
      • Early Talent
      • How We Work
      • Well-being
      • Diversity and Inclusion
      • Career Programs
      • Awards and Recognition
      Careers
    • Coronavirus
    Home
Header
Home Novartis Philippines

Novartis Philippines

At Novartis, we are reimagining medicine

Previous Next
Novartis in the Philippines

Novartis in the Philippines

Learn more about Novartis and our impact on patients, families, and their communities.

Learn More
The Novartis Commitment to Patients and Caregivers

The Novartis Commitment to Patients and Caregivers

Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives.

Learn More
Novartis Philippines About

About Novartis

We discover and develop breakthrough treatments and find new ways to deliver them to as many people as possible.

Patients and Caregivers

Patients and Caregivers

Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives.

Healthcare Professionals

Healthcare Professionals

Novartis works closely with healthcare professionals around the work to support their treatment of patients and collaborate on unmet needs.

colleagues chatting

People and Culture

Novartis is building an Inspired, Curious and Unbossed culture.

Woman wearing a red shirt

Careers

Our work has touched the lives of over 2 million Filipinos.

Latest news

May 10, 2022

Novartis Philippines launches PIK3CA Testing Program for Breast Cancer

May 06, 2022

Survey reveals delayed diagnosis, heavy disease burden among Filipinos with axial spondyloarthritis

Feb 15, 2022

World Cancer Day 2022: Novartis committed to helping close the gap in cancer care

All News

Novartis Philippines

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • News Archive
  • Stories
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Portfolio
Footer Bottom
© 2022 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for an audience in the Philippines